Additionally, TUBA1C is upregulated in hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC), where it predicts poor prognosis and enhances cell proliferation and migration (67, 68). This evidence concerns the gene TUBA1C and hepatocellular carcinoma.